ARLINGTON, Va. — NACDS grant partners have published articles in the journal Vaccine outlining the results of projects designed to increase adult vaccination. The prevalence of vaccine-preventable diseases in adults remains a significant public health issue in the United States. The demonstration projects were supported both by the Center for Disease Control and Prevention (CDC) and NACDS.
ARLINGTON, Va. — This week, NACDS joined with the nation in looking back on the life and leadership of former President George H.W. Bush. NACDS president and chief executive officer Steven Anderson issued the following reflections: “NACDS has had a wonderful relationship with President Bush and his family for many years. They have always answered
ARLINGTON, Va. — The National Association of Chain Drug Store (NACDS) has provided to the membership a state-by-state overview of the 2018 elections, and their implications for a pro-patient, pro-pharmacy policy agenda. The memo described the election results for state legislative chambers and governor’s races. The state-election analysis follows a previously distributed summary of federal-election
In a memo to NACDS chain and associate members today, NACDS president and chief executive officer Steven Anderson, described detailed results of the 2018 Congressional elections from a pharmacy-specific perspective. The memo described changes in the leadership of key healthcare committees, the election results for Congressional champions of specific pharmacy issues, and other insights. The
ARLINGTON, Va. — NACDS highlighted a newly-released guide from the Centers for Disease Control and Prevention earlier this year in an op-ed in Morning Consult. The guide is even more timely now that it is National Diabetes Month, which brings awareness to a disease that affects nearly 30 million people in the United States—and counting.
ARLINGTON, Va. — Lawmakers back in their congressional districts while Congress is on recess had an opportunity through the NACDS RxIMPACT grassroots advocacy program to discuss with pharmacists the critical repercussions caused by pharmacy direct and indirect remuneration (DIR) fees. House Ways & Means Committee Member Rep. Erik Paulsen (R, Minn.) and House Energy &
ARLINGTON, Va. — NACDS has been invited back to the White House for an event on Wednesday, October 24, that is titled “A Year of Historic Action to Combat the Opioid Crisis.” We also anticipate soon President Trump’s signing of the SUPPORT for Patients and Communities Act – which reflects aspects of all four of the policy
WASHINGTON — Retail pharmacy advocates applauded the House of Representatives for unanimously passing two bipartisan bills that aim to lower drug costs. The bills — the Patient Right to Know Drug Prices Act and the Know the Lowest Price Act — had originated in the Senate, where each had gained earlier approval. The bills were
WASHINGTON — Members of the NACDS Board of Directors traveled to Washington, D.C. last week to meet with ten Senators and Representatives with pivotal leadership and committee posts, with Administration officials, and with key Congressional staff. The Board’s meeting agenda mirrored the NACDS “Access Agenda” — which conveys the sense that just as pharmacists provide
ARLINGTON, Va. – The opioid-abuse-prevention legislation crafted by U.S. Senate and U.S. House of Representatives negotiators reflects aspects of all four of the policy topics recommended by the National Association of Chain Drug Stores (NACDS). The House passed the bill today, and the Senate anticipates voting next week. The SUPPORT for Patients and Communities Act (H.R. 6) includes the
ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS) lauded Congressional leaders for their efforts to empower pharmacists help patients reduce out-of-pocket drug costs. The U.S. House of Representatives approved the Senate-passed versions of the Patient Right to Know Prices Act (S. 2554) and the Know the Lowest Price Act (S. 2553), thus
DENVER — The chain pharmacy industry is going through a period of dramatic transformation, according to Steve Anderson, president and chief executive officer of the National Association of Chain Drug Stores. During the business program at the NACDS Total Store Expo here last month, Anderson highlighted the emerging trade war stemming from President Trump’s tariffs
ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS) is applauding the enactment of an electronic prescribing bill (AB 2789) in California that will help to prevent opioid abuse. California Governor Jerry Brown signed the legislation yesterday. Effective January 1, 2022, the bill will require healthcare practitioners authorized to issue prescriptions to have
ARLINGTON, Va. – The U.S. Senate just passed a package of measures focused on the opioid abuse epidemic, including the Every Prescription Conveyed Securely Act (S. 2460), which is backed by the National Association of Chain Drug Stores (NACDS). The legislation would require electronic prescribing for Schedule II through V controlled substances prescriptions covered under
